Key Message
Homebound individuals face substantial barriers to receiving COVID-19 vaccines as they cannot or rarely leave their homes because of medical, psychiatric, cognitive, functional, transportation-related and social reasons.
There are at least 75,000 Ontarians aged 65 years and above who are homebound, with the majority being women and people aged 85 years and above. Much of this older homebound population requires mobile in-home COVID-19 vaccination, which could be prioritized by residence in high SARS-CoV-2 risk neighbourhoods.
Summary
Background
As the Ontario COVID-19 vaccination program continues to roll out, equitable distribution strategies are essential for those who face barriers to vaccination. One population facing such barriers are homebound adults aged 65 years and above.
As of March 29, 2021, 303,552 or 26.4% of Ontarians aged 75 years and above had neither received one dose of a COVID-19 vaccine nor booked an appointment to receive one, with mass vaccination clinic bookings for that age group declining.
Questions
How many Ontario older adult long-stay home care recipients are homebound?
What are the sociodemographic characteristics of homebound older adults, including residence in high SARS-CoV-2 incidence neighbourhoods?
What are the key logistical considerations for mobile in-home COVID-19 vaccination of homebound older adults?
Findings
Between January 1 and December 31, 2020, there were 76,755 long-stay recipients of publicly funded home care services in Ontario aged 65 years and above who were homebound (1.1% of the Ontario population aged 65 years and above).
Identifying all homebound older Ontarians, over and above those receiving publicly funded homecare services, requires leveraging provincial and regional databases, community- and home-based primary care providers, community support services, neighbourhood ambassadors, and community outreach workers.
Key logistical considerations for mobile in-home vaccination of homebound older adults involve mobilizing and training healthcare professionals and non-clinical staff, ensuring that there is a sufficient number of vaccinators in the field who are well-coordinated, appropriately planning the number of vaccine doses needed, mapping out travel plans, and monitoring and maintaining vaccine temperature during transportation.
Interpretation
Many homebound individuals are currently or will soon be prioritized in Ontario’s COVID-19 vaccination program. With nearly 303,552 or 26.4% of all Ontarians aged 75 years and above having neither received a COVID-19 vaccine nor booked an appointment to receive a COVID-19 vaccine, it is imperative that mobile in-home vaccination outreach is available to the homebound population.
Full Text
Background
As the Ontario COVID-19 vaccination program continues to roll out, equitable distribution strategies are essential for those who face barriers to vaccination.1 One population facing such barriers are homebound adults aged 65 years and above.2 The homebound population is defined as community-dwelling individuals who cannot or rarely leave their homes because of medical, psychiatric, cognitive, functional, transportation-related or social reasons.3,4 Homebound individuals are also at increased risk of SARS-CoV-2 infections transmitted by visitors and home care workers, and COVID-19 hospitalizations and deaths due to their underlying risk factors.
As of March 29, 2021, 303,552 or 26.4% of Ontarians aged 75 years and above had neither received one dose of a COVID-19 vaccine nor booked an appointment to receive one, with bookings for that age group declining.5With the overwhelming majority of older Canadians expressing an intent to receive the COVID-19 vaccine, there may be a substantial proportion of older Ontarians who want to get vaccinated but are unable to attend a vaccination clinic.6
Questions
How many Ontario older adult long-stay home care recipients are homebound?
What are the sociodemographic characteristics of homebound older adults, including residence in high SARS-CoV-2 incidence neighbourhoods?
What are the key logistical considerations for mobile in-home COVID-19 vaccination of homebound older adults?
Findings
Between January 1 and December 31, 2020, there were 76,755 long-stay home care recipients aged 65 years and above who were homebound (1.1% of the Ontario population aged 65 years and above). Of these homebound older adults, 49,714 (64.8%) were women, and 41,304 (53.8%) were aged 85 years and above, 23,884 (31.1%) were aged 75 to 84 years, and 11,567 (15.1%) were aged 65 to 74 years. In Toronto and Peel, the majority of homebound older adults lived in the top 20% of neighbourhoods with the highest cumulative SARS-CoV-2 incidence between January 23, 2020 and January 16, 2021 (Figure 1).7
There are several key logistical considerations when vaccinating homebound older adults.8 Homebound Ontarians requiring mobile in-home COVID-19 vaccination should first be identified through their primary care providers and publicly-funded long-stay home care programs and by leveraging a number of additional channels. Homebound individuals and their caregivers should be able to indicate their requirement for in-home vaccination on provincial and public health nit (PHU) vaccine booking systems or through other mechanisms. Homebound individuals who may have difficulty navigating these systems should be further identified and supported to sign up for vaccination through their primary care providers, home care providers and community support services programs like Meals on Wheels, and by neighbourhood ambassadors and community outreach workers.9
Many community support services use standardized assessments that are similar to those used in home care, which can be used to identify clients who are homebound. Paramedic services, particularly those that operate community paramedicine programs, can further identify older adults that are homebound. Wherever possible, trusted relationships should be leveraged to address any COVID-19 vaccine related questions or concerns and provide education.
The Ontario Ministry of Health has developed guidance documents for the onward transport of COVID-19 vaccines beyond the initial point of delivery and interim guidance for the transport of syringes containing COVID-19 vaccine for exceptional circumstances, including for the vaccination of homebound clients.10 In-home COVID-19 vaccination efforts should involve mobilizing and training healthcare professionals and non-clinical staff to support mobile clinics, which could include primary care providers, home care and public health practitioners, and community paramedics.11 Given the sizeable population of homebound older adults in Ontario and the laborious nature of mobile in-home COVID-19 vaccination, it will be crucial to ensure that there is a sufficient number of vaccinators in the field, and that they are well-coordinated to minimize inefficiencies and duplications.
Mobile in-home COVID-19 vaccination is also resource intensive. Rapidly vaccinating the homebound older adult population will require leveraging existing client and care provider relationships while building the capacity of clinicians within the health system. As an example, the City of Toronto is rolling out three homebound vaccination models in partnership with Ontario Health Toronto Region, regional home care program leads for the City of Toronto, Toronto Paramedic Services, the University Health Network, and local primary care teams in partnership with Toronto Public Health (Figure 2).
Mobile in-home COVID-19 vaccination also requires appropriate planning and logistical support to accurately estimate the number of doses needed, map out travel plans, and ensure the monitoring and maintenance of vaccine temperature during transportation. A sample map of the pre-vaccination, vaccination, post-vaccination and second dose stages of the mobile in-home COVID-19 vaccination process is detailed in Figure 3.
The mobile in-home COVID-19 vaccination protocol developed for the City of Toronto uses the Moderna mRNA vaccine, which has specific storage, transportation and handling requirements.12,13 The Moderna vaccine comes in a 10-dose vial and is stored in freezers between -25°C to -15°C. To maintain the stability of the vaccine, the vials should only be transported in a frozen state. The thawed vaccine can be stored in refrigerators between 2° to 8°C for up to 30 days prior to first use and cannot be refrozen. Unpunctured vials may be stored between 8° to 25°C for up to 12 hours, and once a 10-dose vial is punctured, it must be used within 6 hours. While thawed vials should not be transported, thawed Moderna vaccine drawn up into syringes can be transported in UV protected sleeves for exceptional circumstances, such as vaccinating homebound individuals. Current Ontario Ministry of Health guidance documents maintain that a punctured or diluted vial or syringe with Pfizer-BioNTech COVID-19 vaccine should not be transported.10
In accordance with these storage, transportation, and handling requirements, two protocols have been developed for the vaccination of homebound individuals in the City of Toronto with the Moderna COVID-19 vaccine. Protocol 1 involves drawing up thawed vaccine into syringes at the site of freezing or refrigeration, and then directly transporting the vaccine in syringes in UV protected sleeves for mobile in-home vaccination within 6 hours. Protocol 2 involves transporting the vaccine in frozen vials using specialized reusable temperature-controlled parcel shippers (Credo boxes) and temperature loggers with remote monitoring capability.14 This provides the vaccination teams with the ability to thaw individual vials in the field for mobile in-home vaccination within 6 hours. Any unused vials can be returned to the hub freezer within 3 days if they are still in a frozen state and have been in a Credo box the entire time. These two protocols are detailed in Figures 4 and 5 and can be replicated across the Province of Ontario.
Interpretation
Many of Ontario’s more than 75,000 homebound older adults receiving publicly funded home care services are currently or will soon be prioritized in Ontario’s COVID-19 vaccination program, based on their advanced age, clinical risk factors, and residence in high SARS-CoV-2 incidence neighbourhoods.15 With 303,552 or 26.4% of Ontarians aged 75 years and above having neither received one dose of a COVID-19 vaccine nor booked an appointment to receive one, it is imperative that mobile in-home vaccination outreach is offered to the homebound population for whom this method of vaccination is a necessity and not a convenience, while prioritizing those in high-risk neighbourhoods to be vaccinated first. Additionally, there may be some homebound individuals that could visit COVID-19 vaccine clinics if supported with transportation. Ontario recently made a 3.7-million-dollar commitment to supporting individuals getting vaccinated who have transportation-related barriers.16
The number of homebound individuals identified in our analysis is an underestimate of the total homebound Ontario population for several reasons. First, we only captured long-stay recipients of publicly funded home care, and there is likely another large population of homebound individuals who either rely solely on private home care providers or unpaid family caregivers. Second, the number of homebound individuals who relied on long-stay publicly funded home care services may have been lower than usual in the year 2020, as some individuals may have declined or cancelled services due to pandemic-related fears. To ensure that no homebound older adult is missed, jurisdictions like the City of Toronto will be activating a helpline to identify those requiring mobile in-home vaccination, including those without primary care providers. Other initiatives include the Toronto Public Library mobilizing its staff to reach out to older adult library card holders to support vaccine registration.17
We anticipate that the mobile in-home COVID-19 vaccination process, developed for the City of Toronto could be effectively replicated, and scaled up across the Province of Ontario. As many homebound individuals live with unpaid family or friend caregivers upon whom they are often reliant, and in some cases cannot be left unattended from, mobile in-home COVID-19 vaccination efforts should also include these caregivers. Finally, the approach to identifying homebound older adults and providing mobile in-home COVID-19 vaccination could also be used for other homebound populations such as younger individuals with disabilities.
Methods Used for This Science Brief
We included all Ontario adults aged 65 years and older who received at least one community-based long-stay home care assessment between January 1–December 31, 2020, using the Ontario Home Care Database (HCD). Long-stay home care assessments are completed every 6-12 months using the Resident Assessment Instrument – Home Care (RAI-HC) tool for the approximately 40% of Ontario home care recipients who are “long-stay”, or expected to have care needs beyond 60 days.18–23 We next selected individuals who were homebound, based on a response of “no days” to RAI-HC variable G4b: “in the last 3 days, number of days went out of the house or building in which he/she resides”.
We then reported the age and sex of these homebound individuals as well as their residence in one of Ontario’s 34 PHUs. Finally, we stratified all homebound individuals within a PHU to a neighbourhood risk group based on the cumulative SARS-CoV-2 incidence in its forward sortation area (FSA; the first three characters of the building’s postal code) from the beginning of the COVID-19 pandemic (January 23, 2020) until January 16, 2021, with risk group 1 having the highest incidence and risk group 10 having the lowest incidence, by provincial decile; the methods for deriving these neighbourhood risk categories have been previously described.7
The City of Toronto COVID-19 vaccination strategy for homebound individuals was developed through a collaboration between Ontario Health Toronto Region, regional home care program leads for the City of Toronto, Toronto Paramedic Services, the University Health Network, and local primary care provider teams in partnership with Toronto Public Health. University Health Network Connected Care team provided backbone support that enabled daily steering committee meetings and the coordination of the work streams to develop, pilot and finalize ideal models for mobile in-home COVID-19 vaccination, using both primary care and paramedic vaccinators. University Health Network also leveraged its extensive experience supporting local mobile COVID-19 vaccination efforts in Toronto long-term care, retirement homes, and shelters and other congregate settings led by local primary care teams.
The protocols described in this brief for COVID-19 vaccine storage, transport, and handling were developed by the University Health Network vaccine hub and were piloted first with Ornge for the Operation Remote Immunity campaign, and then further piloted and refined for various local mobile vaccination initiatives, including the distribution of COVID-19 vaccine to other hubs across Ontario.
The development and operationalization of the protocols are aligned with the Ontario Ministry of Health guidance documents for the onward transport of COVID-19 vaccines beyond the initial point of delivery and interim guidance for the transport of syringes containing COVID-19 vaccine for exceptional circumstances.10 SPRINT Senior Care House Calls’ primary care provider team partnered in this process for the development of mobile COVID-19 vaccination models by leveraging pre-existing patient relationships, experience in home-based mass vaccination and expertise in home-based practices. Existing home visiting infrastructure, including scheduling, infection, prevention, and control (IPAC) protocols, and logistics, were adapted to meet the needs of a mass mobile COVID-19 vaccination program.
References
1. Jean-Jacques M, Bauchner H. Vaccine distribution—equity left behind? JAMA. 2021;325(9):829. https://doi.org/10.1001/jama.2021.1205
2. Ozawa S, Yemeke TT, Evans DR, Pallas SE, Wallace AS, Lee BY. Defining hard-to-reach populations for vaccination. Vaccine. 2019;37(37):5525-5534. https://doi.org/10.1016/j.vaccine.2019.06.081
3. Stall N, Nowaczynski M, Sinha SK. Back to the future: home-based primary care for older homebound Canadians: Part 1: where we are now. Can Fam Physician. 2013;59(3):237-240.
4. Qiu WQ, Dean M, Liu T, et al. Physical and mental health of homebound older adults: an overlooked population. J Am Geriatr Soc. 2010;58(12):2423-2428. https://doi.org/10.1111/j.1532-5415.2010.03161.x
5. Crawley M. Nearly 200,000 Ontarians age 80+ have not signed up for a COVID-19 vaccine. CBC. Published March 23, 2021. Accessed March 25, 2021. https://www.cbc.ca/news/canada/toronto/covid-19-vaccine-ontario-booking-appointments-1.5958792
6. Government of Canada SC. Majority of Canadians intend to get the COVID-19 vaccine, September 2020. Statistics Canada. Published December 17, 2020. Accessed March 25, 2021. https://www150.statcan.gc.ca/n1/daily-quotidien/201217/dq201217c-eng.htm
7. Brown KA, Stall NM, Joh E, et al. A strategy for the mass distribution of COVID-19 vaccines in Ontario based on age and neighbourhood. Sci Briefs Ont COVID-19 Sci Advis Table. 2021;2(10). https://doi.org/10.47326/ocsat.2021.02.10.1.0
8. Ianzito C. Another COVID-19 challenge: vaccinating the homebound. AARP. Published March 4, 2021. https://www.aarp.org/health/conditions-treatments/info-2021/covid-vaccines-for-homebound.html
9. City of Toronto. City of Toronto provides updated details of city COVID-19 vaccination program and collaboration with health sector partners. City of Toronto. Published March 1, 2021. https://www.toronto.ca/news/city-of-toronto-provides-updated-details-of-city-covid-19-vaccination-program-and-collaboration-with-health-sector-partners/
10. Ministry of Health and Long-Term Care. COVID-19 vaccine-relevant information and planning resources. Government of Ontario. Published March 24, 2021. https://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/covid19_vaccine.aspx
11. Centers for Disease Control and Prevention (CDC). Vaccinating homebound persons with COVID-19 vaccine. Centers for Disease Control and Prevention. Published March 2, 2021. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/homebound-persons.html
12. Government of Canada. Recommendations on the use of COVID-19 vaccines. Canada.ca. Published March 16, 2021. Accessed March 31, 2021. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines.html
13. Health Canada. Product Monograph Including Patient Medication Information: COVID-19 Vaccine Moderna. Government of Canada; 2021. Accessed March 31, 2021. https://covid-vaccine.canada.ca/info/pdf/covid-19-vaccine-moderna-pm-en.pdf
14. Pelican BioThermal. Reusable passive thermal packaging. Published 2021. Accessed March 31, 2021. https://pelicanbiothermal.com/thermal-packaging/reusable-parcel
15. Ministry of Health. COVID-19: Guidance for Priotization of Phase 2 Populations for COVID-19 Vaccination. Government of Ontario; 2021. https://www.afhto.ca/sites/default/files/2021-03/Phase%202%20Prioritization%20for%20COVID-19%20Vaccination%202021-03-22%20FINAL%20SHARE.pdf
16. Government of Ontario. Ontario helping people get their COVID-19 vaccination. Ontario.ca. Published March 23, 2021. Accessed March 31, 2021. https://news.ontario.ca/en/release/60871/ontario-helping-people-get-their-covid-19-vaccination
17. City of Toronto. City of Toronto continuing COVID-19 vaccine outreach to seniors. Toronto.ca. Published March 22, 2021. Accessed March 31, 2021. https://www.toronto.ca/news/city-of-toronto-continuing-covid-19-vaccine-outreach-to-seniors/
18. Poss J. Mind the Gap? Looking at Reassessment Patterns among Ontario Longstay Home Care Clients. Canadian InterRAI Conference; 2009.
19. Poss JW, Jutan NM, Hirdes JP, et al. A review of evidence on the reliability and validity of Minimum Data Set data. Healthc Manage Forum. 2008;21(1):33-39. https://doi.org/10.1016/S0840-4704(10)60127-5
20. Landi F, Tua E, Onder G, et al. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care. 2000;38(12):1184-1190. https://doi.org/10.1097/00005650-200012000-00005
21. Hirdes JP, Ljunggren G, Morris JN, et al. Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system. BMC Health Serv Res. 2008;8(1):277. https://doi.org/10.1186/1472-6963-8-277
22. Health Quality Ontario. Home Care Indicator Review: Summary Report. Government of Ontario; 2017. Accessed December 14, 2020. https://hqontario.ca/Portals/0/documents/system-performance/home-care-indicator-review-report-2017.pdf
23. Ministry of Health and Long-Term Care. Presentation to the Premier’s Council on Improving Healthcare & Ending Hallway Medicine. Government of Ontario; 2018.
Document Information & Citation
Author Contributions: NMS conceived the Science Brief and wrote the first draft. All authors revised the Science Brief critically for important intellectual content and approved the final version.
Citation: Stall NM, Nakamachi Y, Chang M, et al. Mobile in-home COVID-19 vaccination of Ontario homebound older adults by neighbourhood risk. Science Briefs of the Ontario COVID-19 Science Advisory Table. 2021;1(19). https://doi.org/10.47326/ocsat.2021.02.19.1.0
Author Affiliations: The affiliations of the members of the Ontario COVID-19 Science Advisory Table can be found at https://covid19-sciencetable.ca/.
Declarations of Interest: The declarations of interest of the members of the Ontario COVID-19 Science Advisory Table, its Working Groups, or its partners can be found at https://covid19-sciencetable.ca/. The declarations of interest of external authors can be found under additional resources.
Copyright: 2021 Ontario COVID-19 Science Advisory Table. This is an open access document distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
The views and findings expressed in this Science Brief are those of the authors and do not necessarily reflect the views of all of the members of the Ontario COVID-19 Science Advisory Table, its Working Groups, or its partners.